Free tool
FAERS Monitor: Mucinex D
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021585 or its brand name (Mucinex D, Guaifenesin, Pseudoephedrine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
1,816
Serious
694
38% of reports
Hospitalization
213
Death reported
58
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective147
- insomnia146
- dizziness129
- headache112
- nausea108
- fatigue105
- dyspnoea85
- accidental overdose76
- cough72
- sinusitis71
- diarrhoea69
- pain68
- overdose64
- anxiety63
- vomiting59
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 8 |
| 2009 | 20 |
| 2010 | 58 |
| 2011 | 34 |
| 2012 | 52 |
| 2013 | 78 |
| 2014 | 59 |
| 2015 | 132 |
| 2016 | 227 |
| 2017 | 223 |
| 2018 | 175 |
| 2019 | 147 |
| 2020 | 151 |
| 2021 | 57 |
| 2022 | 96 |
| 2023 | 96 |
| 2024 | 87 |
| 2025 | 79 |
| 2026 | 26 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,343 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| accidental overdoseSignal | 76 | 24.1 | 19.3 | 1,660 |
| sinusitisSignal | 71 | 8.0 | 6.4 | 432 |
| insomniaSignal | 146 | 6.4 | 5.4 | 661 |
| overdoseSignal | 64 | 3.4 | 2.7 | 109 |
| dizzinessSignal | 129 | 3.0 | 2.5 | 174 |
| coughSignal | 72 | 3.0 | 2.4 | 94 |
| anxietySignal | 63 | 2.6 | 2.0 | 59 |
| headacheSignal | 112 | 2.1 | 1.7 | 63 |
| dyspnoea | 85 | 1.7 | 1.4 | 27 |
| nausea | 108 | 1.6 | 1.3 | 23 |
| fatigue | 105 | 1.6 | 1.3 | 21 |
| vomiting | 59 | 1.5 | 1.1 | 8 |
| drug ineffective | 147 | 1.3 | 1.1 | 10 |
| pain | 68 | 1.3 | 1.0 | 4 |
| diarrhoea | 69 | 1.2 | 1.0 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.